Scientific and professional concerns regarding product interchange and subsequent monitoring of cyclosporine and other critical dose drugs.
D002626:Chemistry, Pharmaceutical / Q000592:standards; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000592:standards; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000592:standards; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration